The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Fatigue in IBD 1 year after diagnosis does not appear to be less prevalent even when applying stricter definitions of disease ...

Work-related stress is associated with worse cardiovascular health, underscoring the importance of workplace psychological ...

Influenza vaccine is effective for preventing severe influenza illness among children, according to study findings.

HealthDay News — In a special communication issued by the International Antiviral Society-USA Panel and published online Dec. 1 in the Journal of the American Medical Association, the latest ...

HealthDay News — Reporting of human adenovirus (HAdV) types decreased since the COVID-19 pandemic, according to research ...

Federal health officials have confirmed unsettling new details about the first United States case of severe bird flu, reported recently in a hospitalized patient in Louisiana.

The pediatric BNT162b2 vaccine is safe among children aged between 5 and 11 years with and without comorbidities.

The risk for ventilator-associated pneumonia (VAP) in patients receiving mechanical ventilation in the ICU is less in those ...

Children diagnosed with inflammatory bowel disease (IBD) face a significantly higher risk for venous thromboembolism (VTE) ...

For patients hospitalized for COVID-19, administration of therapeutic-dose vs prophylactic-dose anticoagulation with heparins ...